{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:47:00Z","timestamp":1790390820195,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1053\/j.ajkd.2019.01.022","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T09:26:26Z","timestamp":1553246786000},"page":"417-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient"],"prefix":"10.1053","volume":"74","author":[{"given":"Matthew R.","family":"D\u2019Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.","family":"Milliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Norby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaTonya J.","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2019.01.022_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1534735414534463","article-title":"Intravenous vitamin C and cancer: a systematic review","volume":"13","author":"Fritz","year":"2014","journal-title":"Integr Cancer Ther"},{"key":"10.1053\/j.ajkd.2019.01.022_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"key":"10.1053\/j.ajkd.2019.01.022_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/sdi.12099","article-title":"Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review","volume":"26","author":"Clase","year":"2013","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2019.01.022_bib4","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/ndt\/gfh260","article-title":"Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis","volume":"19","author":"Deicher","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2019.01.022_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrneph.2012.113","article-title":"An update on primary hyperoxaluria","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11926-013-0340-4","article-title":"Update on oxalate crystal disease","volume":"15","author":"Lorenz","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1053\/j.ajkd.2019.01.022_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.ajkd.2013.01.025","article-title":"Oxalate nephropathy and intravenous vitamin C","volume":"61","author":"Cossey","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2019.01.022_bib8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/archopht.1989.01070020716035","article-title":"Retinal oxalosis. A clinicopathologic report","volume":"107","author":"Wells","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2018.1523","article-title":"Retinal oxalosis in end-stage renal disease","volume":"136","author":"Scruggs","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000360624","article-title":"Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria","volume":"39","author":"Tang","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/odi.12446","article-title":"Vitamin C physiology: the known and the unknown and Goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis"},{"key":"10.1053\/j.ajkd.2019.01.022_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00240-016-0868-7","article-title":"Ascorbic acid intake and oxalate synthesis","volume":"44","author":"Knight","year":"2016","journal-title":"Urolithiasis"},{"key":"10.1053\/j.ajkd.2019.01.022_bib13","first-page":"239","article-title":"Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients","volume":"26","author":"Ono","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib14","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney inter., Suppl"},{"key":"10.1053\/j.ajkd.2019.01.022_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0925-4439(00)00009-0","article-title":"The non-oxidative degradation of ascorbic acid at physiological conditions","volume":"1501","author":"Simpson","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.ajkd.2019.01.022_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2215\/CJN.01410308","article-title":"Determinants of 24-hour urinary oxalate excretion","volume":"3","author":"Taylor","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0955-2863(98)00002-3","article-title":"Absorption, transport, and disposition of ascorbic acid in humans","volume":"9","author":"Rumsey","year":"1998","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1053\/j.ajkd.2019.01.022_bib18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.clinbiochem.2017.07.017","article-title":"Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease","volume":"50","author":"Perinpam","year":"2017","journal-title":"Clin Biochem"},{"key":"10.1053\/j.ajkd.2019.01.022_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICB.0000000000000272","article-title":"Crystalline retinopathy from hyperoxaluria: long-term follow-up","volume":"11","author":"Sangave","year":"2017","journal-title":"Retinal Cases Brief Rep"},{"key":"10.1053\/j.ajkd.2019.01.022_bib20","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.022_bib21","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbadis.2012.06.014","article-title":"4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition","volume":"1822","author":"Riedel","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.ajkd.2019.01.022_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1525-1594.1998.06220.x","article-title":"Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis","volume":"22","author":"Mydlik","year":"1998","journal-title":"Artif Organs"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619301271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619301271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:23:11Z","timestamp":1759461791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619301271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0272638619301271"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.022","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}